Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Stem Cell Reviews and Reports|April 14, 2022
Industrialized GMP Production of CD34+ Cells (ProtheraCytes®) at Clinical Scale for Treatment of Ischemic Cardiac Diseases Is Feasible and SafePhilippe Hénon, Marc Kowalczyk, Anne Aries, et al.
Plos One|August 13, 2013
Flow cytometric quantification of all phases of the cell cycle and apoptosis in a two-color fluorescence plotChristine Vignon, Christelle Debeissat, Marie-Thérèse Georget, et al.
Scientific Reports|November 11, 2023
Development of a potency assay for CD34+ cell-based therapyAnne Aries, Christine Vignon, Céline Zanetti, et al.
Stem Cells Translational Medicine|November 28, 2023
Probing Multiple Transplant Delivery Routes of CD+34 Stem Cells for Promoting Behavioral and Histological Benefits in Experimental Ischemic StrokeJea-Young Lee, Justin Cho, Francesco D'Egidio, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|May 3, 2026
Development and Validation of Flow Cytometry-Based Method to Quantify CD34/CD45+ Cells as a Release Criterion of Clinical-Grade Products for a Phase III Clinical TrialDelphine Bouis, Aurélien Goubaud, Arthur Cormier, et al.
Frontiers in Bioengineering and Biotechnology|June 8, 2023
Evaluation of expanded peripheral blood derived CD34+ cells for the treatment of moderate knee osteoarthritisChristine Vignon, Morgane Hilpert, Karine Toupet, et al.
Scientific Reports|August 12, 2025
Validation of a potency assay for CD34 + cell based therapyChristine Vignon, Arthur Cormier, Aurélien Goubaud, et al.
Cytometry. Part B, Clinical Cytometry|September 5, 2020
Reactive oxygen species levels differentiate CD34+ human progenitors based on CD38 expressionChristine Vignon, Sébastien Lachot, Amélie Foucault, et al.
Blood Advances|December 24, 2019
Bone marrow oxidative stress and specific antioxidant signatures in myelodysplastic syndromesFrederic Picou, Christine Vignon, Christelle Debeissat, et al.
Biochemical and Biophysical Research Communications|March 19, 2018
Superoxide dismutase 2 (SOD2) contributes to genetic stability of native and T315I-mutated BCR-ABL expressing leukemic cellsSandrine Girerd, Lucie Tosca, Olivier Herault, et al.
Pageof 2